Heinrich Bürgin

775 total citations
18 papers, 510 citations indexed

About

Heinrich Bürgin is a scholar working on Molecular Biology, Cancer Research and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Heinrich Bürgin has authored 18 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Heinrich Bürgin's work include Retinoids in leukemia and cellular processes (6 papers), Carcinogens and Genotoxicity Assessment (5 papers) and Pregnancy and Medication Impact (3 papers). Heinrich Bürgin is often cited by papers focused on Retinoids in leukemia and cellular processes (6 papers), Carcinogens and Genotoxicity Assessment (5 papers) and Pregnancy and Medication Impact (3 papers). Heinrich Bürgin collaborates with scholars based in Switzerland, Germany and United States. Heinrich Bürgin's co-authors include H. J. Schatzmann, Georg Tzimas, Hans Hummler, Michael D. Collins, Heinz Nau, Elmar Gocke, Lutz Müller, Thomas D. Pfister, Nicole Clemann and Marc Schmid and has published in prestigious journals such as The Journal of Physiology, Annals of the New York Academy of Sciences and Journal of Nutrition.

In The Last Decade

Heinrich Bürgin

18 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heinrich Bürgin Switzerland 13 318 69 65 61 60 18 510
Shannon Sullivan United States 10 305 1.0× 30 0.4× 111 1.7× 48 0.8× 68 1.1× 13 583
Francis Fouchier France 13 202 0.6× 27 0.4× 39 0.6× 18 0.3× 68 1.1× 25 434
Jeffrey P. Rabek United States 15 551 1.7× 28 0.4× 135 2.1× 56 0.9× 60 1.0× 29 899
D A Freeman United States 16 305 1.0× 100 1.4× 147 2.3× 38 0.6× 40 0.7× 22 701
D R Crawford United States 11 337 1.1× 37 0.5× 29 0.4× 12 0.2× 70 1.2× 11 602
Caroline Jacques France 12 396 1.2× 25 0.4× 70 1.1× 160 2.6× 99 1.6× 19 678
E Sugimoto Japan 13 258 0.8× 41 0.6× 56 0.9× 17 0.3× 24 0.4× 20 564
Manisha Sonee United States 14 203 0.6× 10 0.1× 32 0.5× 52 0.9× 62 1.0× 26 586
Kimberly D. Jacob United States 9 282 0.9× 30 0.4× 42 0.6× 12 0.2× 95 1.6× 10 485
Mignon Keaton United States 17 627 2.0× 49 0.7× 57 0.9× 18 0.3× 72 1.2× 21 845

Countries citing papers authored by Heinrich Bürgin

Since Specialization
Citations

This map shows the geographic impact of Heinrich Bürgin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heinrich Bürgin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heinrich Bürgin more than expected).

Fields of papers citing papers by Heinrich Bürgin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heinrich Bürgin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heinrich Bürgin. The network helps show where Heinrich Bürgin may publish in the future.

Co-authorship network of co-authors of Heinrich Bürgin

This figure shows the co-authorship network connecting the top 25 collaborators of Heinrich Bürgin. A scholar is included among the top collaborators of Heinrich Bürgin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heinrich Bürgin. Heinrich Bürgin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Morinello, Eric J., et al.. (2014). Embryofetal Development Study of Vismodegib, a Hedgehog Pathway Inhibitor, in Rats. Birth Defects Research Part B Developmental and Reproductive Toxicology. 101(2). 135–143. 18 indexed citations
2.
Sakurai, Takayuki, Heinrich Bürgin, Yuichiro Sakamoto, et al.. (2013). The Effects of Interleukin‐6 Signal Blockade on Immune System, Reproductive and Skeletal Development in Juvenile Mice. Birth Defects Research Part B Developmental and Reproductive Toxicology. 98(2). 170–182. 6 indexed citations
3.
Sakurai, Takayuki, Heinrich Bürgin, Yuichiro Sakamoto, et al.. (2012). The Effects of Interleukin‐6 Signal Blockade on Fertility, Embryo‐fetal Development, and Immunization In vivo. Birth Defects Research Part B Developmental and Reproductive Toxicology. 95(4). 304–317. 24 indexed citations
4.
Gocke, Elmar, Heinrich Bürgin, Lutz Müller, & Thomas D. Pfister. (2009). Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate. Toxicology Letters. 190(3). 254–265. 65 indexed citations
5.
Bürgin, Heinrich, et al.. (2007). The embryonic stem cell test for the early selection of pharmaceutical compounds. ALTEX. 24(1). 3–7. 29 indexed citations
6.
Chou, Ruby C., Heinrich Bürgin, G Schmitt, & Herwig Eggers. (1997). Absorption of tretinoin in rats and rabbits following oral and dermal application.. PubMed. 47(4). 401–5. 7 indexed citations
7.
Tzimas, Georg, Michael D. Collins, Heinrich Bürgin, Hans Hummler, & Heinz Nau. (1996). Embryotoxic Doses of Vitamin A to Rabbits Result in Low Plasma but High Embryonic Concentrations of All-trans-Retinoic Acid: Risk of Vitamin A Exposure in Humans. Journal of Nutrition. 126(9). 2159–2171. 28 indexed citations
8.
Collins, Michael D., Georg Tzimas, Heinrich Bürgin, Hans Hummler, & Heinz Nau. (1995). Single Versus Multiple Dose Administration of All-trans-retinoic Acid during Organogenesis: Differential Metabolism and Transplacental Kinetics in Rat and Rabbit. Toxicology and Applied Pharmacology. 130(1). 9–18. 28 indexed citations
10.
Collins, Michael D., Georg Tzimas, Hans Hummler, Heinrich Bürgin, & Heinz Nau. (1994). Comparative Teratology and Transplacental Pharmacokinetics of All-trans-Retinoic Acid, 13-cis-Retinoic Acid, and Retinyl Palmitate Following Daily Administrations in Rats. Toxicology and Applied Pharmacology. 127(1). 132–144. 60 indexed citations
11.
Hofheinz, W., Heinrich Bürgin, Elmar Gocke, et al.. (1994). Ro 42-1611 (arteflene), a new effective antimalarial: chemical structure and biological activity.. PubMed. 45(3). 261–5. 33 indexed citations
12.
Tsuchiya, Toshie, Kazuhiro Eto, Heinrich Bürgin, & Andreas D. Kistler. (1992). Micromass Culture of Midbrain Cells and its Relevance to in Vitro Mechanistic Studies*. Congenital Anomalies. 32(2). 105–116. 4 indexed citations
13.
Tsuchiya, Toshie, et al.. (1991). Embryolethality of new herbicides is not detected by the micromass teratogen tests. Archives of Toxicology. 65(2). 145–149. 15 indexed citations
14.
Bürgin, Heinrich, et al.. (1988). Toxicological investigations with the benzodiazepine antagonist flumazenil.. PubMed. 38(2). 247–50. 5 indexed citations
15.
Bürgin, Heinrich. (1979). The role of calcium in the mechanical performance of cattle ruminal muscle. Journal of Veterinary Pharmacology and Therapeutics. 2(4). 305–311. 2 indexed citations
16.
Bürgin, Heinrich, Marc Schmid, & G. Zbinden. (1979). Assessment of DNA damage in germ cells of male rabbits treated with isoniazid and procarbazine. Toxicology. 12(3). 251–257. 17 indexed citations
17.
Bürgin, Heinrich & H. J. Schatzmann. (1979). The relation between net calcium, alkali cation and chloride movements in red cells exposed to salicylate.. The Journal of Physiology. 287(1). 15–32. 33 indexed citations
18.
Schatzmann, H. J. & Heinrich Bürgin. (1978). CALCIUM IN HUMAN RED BLOOD CELLS. Annals of the New York Academy of Sciences. 307(1). 125–147. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026